MetLife, Inc.

NYSE:MET

Insurance - Life

Financial Services
$99.79 -0.17%

-$0.15 today

Market cap
$62.71B
Beta
0.78
P/E (TTM)
15.4
EPS (TTM)
$5.55
Dividend yield
2.68%
52W Low $67.33High $89.62

Volume 4.27M

Average 3.49M

MET EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

MetLife, Inc.NYSE: MET

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA growth accelerates

Q2 FY2026 EBITDA of $1.33B rose 6.2% year over year, ahead of the -11.7% change in trailing-twelve-month EBITDA. Sequentially, it fell 25.1% from the prior quarter. Over 3 fiscal years it compounded at -6.7% a year.

Context

  • EBITDA amounted to 8.4% of revenue in FY2025, down 2.1 pp from a year earlier.
  • EBITDA increased in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 6 analysts of $9.07B (+40.1%) for the fiscal year ending Dec 2026, a step up from the -12.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.33B-25.1% QoQ
Last fiscal yearDec 2025
$6.48B-12.2% YoY
LTMJun 2026
$5.96B-11.7% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.2%+60.4%+54.1 pp
1 year-12.2%+40.1%+52.3 pp
3-year CAGR-6.7%+18.8%+25.6 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
6.48B USD
Year-over-year change
-12.2%
4-year CAGR
-10.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How MET compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -11.7% is the 7th highest of 11, against a peer median of -3.3%.
  • EBITDA amounts to 7.6% of revenue for MET, versus a peer median of 16.9%.
MET Competitors
EBITDA for MET and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MFCManulife Financial CorporationLTM Jun 2026CA$9.34B CAD+24.5%—16.1%
AFLAflac IncorporatedLTM Jun 2026$7.11B USD+122.7%+4.5%39.3%
METMetLife, Inc.LTM Jun 2026$5.96B USD-11.7%-6.7%7.6%
PRUPrudential Financial, Inc.LTM Jun 2026$5.28B USD+120.4%—8.1%
LNCLincoln National CorporationLTM Jun 2026$3.16B USD+104.5%-8.9%16.3%
UNMUnum GroupLTM Jun 2026$1.26B USD-43.8%-14.8%9.5%
VOYAVoya Financial, Inc.LTM Jun 2026$948M USD-5.1%-24.7%25.2%
BHFBrighthouse Financial, Inc.LTM Sep 2026$946M USD-27.8%-49.6%17.4%
CNOCNO Financial Group, Inc.LTM Jun 2026$901.1M USD-1.6%-11.2%19.4%
PRIPrimerica, Inc.LTM Sep 2026$785.19M USD-20.6%+9.3%22.7%
GLGlobe Life Inc.LTM Sep 2026$596.82M USD-61.8%+10.1%9.5%
Peer median (excluding MET) —-3.3%-10.1%16.9%

Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue63.37B67.97B67.71B69.94B77.08B
Cost of Revenue46.53B49.03B50.42B50.94B49.06B
Gross Profit16.84B18.94B17.29B19B28.02B
Gross Margin26.6%27.9%25.5%27.2%36.4%
Research & Development00000
Selling, General & Admin5.76B5.86B6.18B5.99B0
Operating Expenses8.32B12.57B15.13B13.38B23.36B
Depreciation & Amortization694M673M718M714M753M
EBITDA10.13B7.98B3.93B7.37B6.48B
EBITDA Margin16.0%11.7%5.8%10.5%8.4%
Operating Income8.52B6.36B2.16B5.62B4.66B
Operating Margin13.4%9.4%3.2%8.0%6.0%
Interest Income00000
Interest Expense920M938M1.05B1.04B1.06B
Other Income / Expenses00000
Income Before Tax8.52B6.36B2.16B5.62B4.66B
Pre-Tax Margin13.4%9.4%3.2%8.0%6.0%
Income Tax Expense1.64B1.06B560M1.18B1.26B
Net Income6.86B5.28B1.58B4.43B3.38B
Net Margin10.8%7.8%2.3%6.3%4.4%
EPS (Basic)7.706.351.825.984.80
EPS (Diluted)7.656.301.815.944.80
Weighted Avg Shares825.54M779.1M762.43M689.21M664.96M
Weighted Avg Shares (Diluted)869.4M808.9M762.43M711.1M664.96M

MetLife, Inc.

NYSE:MET

Intrinsic Alpha fair value

Locked

Current Price

$99.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.